Study (A–Z) | Participants N, status, gender | Exercise type, HIIT work interval intensity, MICT intensity | Sessions week-1 | Weeks | Outcomes |
Ciolac et al64 | 22 healthy ♀ | Treadmill walking or running HIIT: 80%–90% VO2MAX, MICT: 60%–70% VO2MAX | 3 | 16 | TC, TRG, HDL-C, LDL-C |
Connolly et al65 | 30 healthy ♀ | Ergocycle HIIT: 30–<100% sprint, MICT: 70%–85% HRPEAK | 3 | 12 | TC, TRG, HDL-C, LDL-C, TC/HDL-C |
Cuddy et al66 | 27 Ov–Ob ♀♂ | Ergocycle HIIT: 100% sprint; MICT: 40%–65% HRR | HIIT: 2–4 MICT: 3–5 | 8 | TRG, HDL-C |
Fisher et al76 | 23 Ov–Ob ♂ | Ergocycle HIIT: 85% sprint, MICT: 55%–65% VO2PEAK | HIIT: 3 MICT: 5 | 6 | TC, TRG, HDL-C, LDL-C |
Hwang et al67 | 29 Ov ♀♂ | All-extremity ergometer HIIT: 90% HRPEAK, MICT: 70% HRPEAK | 4 | 8 | TC, TRG, HDL-C, LDL-C |
Keating et al68 | 22 Ov ♀♂ | Ergocycle HIIT: 120% VO2PEAK, MICT: 50%–65% VO2PEAK | 3 | 12 | TC, TRG, HDL-C, LDL-C |
Kemmler et al24 | 65 Ov–MetS ♂ | Running HIIT: 95%–110% HRIAT*, MICT: 70%–82.5% HRIAT* | 2–4 | 16 | TRG, HDL-C |
Kong et al69 | 26 Ob♀ | Ergocycle HIIT: max VO2PEAK, MICT: 60%–80% VO2PEAK | 4 | 5 | TC, TRG, HDL-C, LDL-C |
Lee, et al a61 | 20 healthy ♂ | Ergocyle HIIT: 85%–90% VO2MAX, MICT: not stated | 3 | 4 | TC, TRG, HDL-C, LDL-C |
Lee, et al b61 | 18 healthy ♂ | Ergocycle HIIT: 85%–90% VO2MAX, MICT: not stated | 3 | 4 | TC, TRG, HDL-C, LDL-C |
Lira et al70 | 20 healthy ♂ | Treadmill HIIT: 100% sVO2PEAK, MICT: 70% sVO2PEAK | 3 | 5 | TC, TRG, HDL-C |
Maillard et al77 | 16 Ov–Ob, T2D♀ | Ergocycle HIIT: 80% MHR, MICT: 55%–60% target HR | 2 | 16 | TC, TRG, HDL-C, LDL-C, TC/HDL-C |
Matsuo et al75 | 26 Ov–MetS ♂ | Ergocycle HIIT: 85% VO2PEAK, MICT: 60%–65% VO2PEAK | 3 | 8 | TC, TRG, HDL-C, LDL-C, TC/HDL-C |
Mohr et al71 | 42 hours, Ov ♀ | Free-style swimming HIIT: 85%–95% MHR, MICT: 72%–79% MHR | 3 | 15 | TC, HDL-C, LDL-C |
Morales-Palermo et al a62 | 50 MetS♀♂ | Ergocycle HIIT4: 90% MHR, MICT: 70% MHR | 3 | 16 | TC, TRG, HDL-C, LDL-C |
Morales-Palermo et al b62 | 49 MetS♀♂ | Ergocycle HIIT1:100% MHR, MICT: 70% MHR | 3 | 16 | TC, TRG, HDL-C, LDL-C |
Moreira et al72 | 16 Ob ♀♂ | Ergocycle HIIT: 60%–72% VO2MAX, MICT: 55%–66% VO2MAX | 3 | 12 | TC, TRG |
Nybo et al73 | 17 healthy ♂ | Running HIIT: 85% VO2MAX, MICT: 65% VO2MAX | 3 | 12 | TC, HDL-C, LDL-C, TC/HDL-C |
Ramos et al58 | 32 MetS, T2D ♀♂ | Walking/running, ergocycle/cycling, swimming HIIT: 85%–95% HRPEAK, MICT: 60%–70% HRPEAK | HIIT: 3 MICT: 5 | 16 | TRG, HDL-C |
Ruffino et al78 | 16 Ov–Ob, T2D ♂ | Ergocycle, walking HIIT: 80%–90% MHR, MICT: 50%–55% HRR | HIIT: 3 MICT: 5 | 8 | TRG, HDL-C, LDL-C |
Sawyer et al79 | 18 Ob ♀♂ | Ergocycle HIIT: 90%–95% MHR, MICT: 70%–75% MHR | 3 | 8 | TC, TRG, HDL-C, LDL-C |
Shepherd et al74 | 78 Ov ♀♂ | Ergocycle HIIT:>90% MHR, MICT: 70% MHR | HIIT: 3 MICT: 5 | 10 | TC, TRG, HDL-C, LDL-C, LDL-C/HDL-C |
Thomas et al a63 | 14 healthy ♂ | Running HIIT: 90%–100% MHR, MICT: 75%–85% MHR | 3 | 11 | TC, HDL-C |
Thomas et al b63 | 14 healthy ♂ | Running HIIT: 90%–100% MHR, MICT: 75%–85% MHR | 3 | 11 | TC, HDL-C |
Tjønna et al55 | 19 MetS ♀♂ | Treadmill walking and running HIIT: 90% MHR, MICT: 70% MHR | 3 | 8 | TRG, HDL-C |
Vella et al25 | 17 Ov–Ob ♀♂ | Treadmill, ergocycle, elliptical HIIT: 75%–80% HRR, MICT: 55%–59% HRR | 4 | 8 | TC, TRG, HDL-C, LDL-C |
Winding et al80 | 25 Ov, T2D ♀♂ | Ergocycle HIIT: 95% WPEAK, MICT: 50% WPEAK | 3 | 11 | TC, TRG, HDL-C, LDL-C |
Winn et al81 | 16 Ob ♀♂† | Treadmill walking and running HIIT: 80% VO2PEAK, MICT: 55% VO2PEAK | 4 | 4 | TC, TRG, HDL-C, LDL-C |
Zhang et al82 | 24 Ob ♀ | Treadmill running HIIT: 50%–95% HRPEAK, MICT: 60%–70% HRPEAK | 4 | 12 | TC, TRG |
*HRIAT—HR at indvidual aerobic thershold IAt (minimum lactate 2.0 mmol/L).
†Assumed. Gender not specified.
HDL-C, High-density lipoprotein cholesterol; HIIT, High intensity interval training; HR, Heart rate; HRPEAK, Peak heart rate; HRR, Heart rate reserve; IAT, individual anaerobic threshold; LDL-C, Low-density lipoprotein cholesterol; MetS, Metabolic Syndrome; MHR, maximal heart rate; MICT, Moderate intensity continuous training; Ob, Obesity; Ov, Overweight; PICO, Participants, Intervention, Comparator, Outcome; TC, Total cholesterol; T2D, Type 2 diabetes mellitus; TRG, Triglycerides; VO2PEAK,VO2MAX, Peak oxygen consumption; WPEAK, Workload or watts.